Iridex (IRIX) Free Cash Flow Growth (5y) (2016 - 2026)
Iridex (IRIX) Free Cash Flow Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Iridex | 13.27 Mn | 8.59 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -16.23% |
| Sep 27, 2025 | -36.07% |
| Jun 28, 2025 | 29.10% |
| Mar 29, 2025 | 6.09% |
| Dec 28, 2024 | -48.30% |
| Sep 28, 2024 | -1.66% |
| Jun 29, 2024 | 0.32% |
| Mar 30, 2024 | 15.30% |
| Dec 30, 2023 | 13.38% |
| Sep 30, 2023 | 8.03% |
| Jul 1, 2023 | 13.06% |
| Apr 1, 2023 | -0.94% |
| Dec 31, 2022 | -10.59% |
| Oct 1, 2022 | -14.71% |
| Jul 2, 2022 | -41.86% |
| Apr 2, 2022 | -10.81% |
| Jan 1, 2022 | 82.46% |
| Apr 3, 2021 | 93.59% |
| Mar 28, 2020 | -33.85% |
| Sep 28, 2019 | -34.65% |